Actinic Keratosis: What Aesthetic Practitioners Should Know

Aesthetic clinics see a great deal of sun-affected skin, and not all of it is purely cosmetic. Actinic keratosis is one of the more common findings on cumulatively sun-exposed skin, and it sits in a category practitioners should recognise even when its management falls to a dermatologist or prescribing clinician. This overview is educational, not diagnostic or medical advice, and treatment decisions belong with an appropriately qualified clinician.

What Actinic Keratosis Is

Actinic keratosis presents as rough, scaly, sometimes raised patches of skin, typically smaller than a centimetre and often multiple in number within a sun-exposed area. It appears most frequently on the face, scalp, ears, neckline, forearms, and the backs of the hands — the surfaces that accumulate the most lifetime ultraviolet exposure. Patches can appear pink, brown, or red, with a dry, crusted texture, and the surrounding skin is sometimes mildly inflamed.

The underlying cause is cumulative ultraviolet exposure. UVA and UVB radiation damage the outer layer of skin cells over years, progressively impairing their ability to repair themselves and regulate normal growth. Fair skin, light eye colour, a history of significant sunburn, and age over fifty are all associated with higher risk, alongside simple lifetime sun exposure.

Why It Is More Than a Cosmetic Concern

Actinic keratosis sits on a spectrum. In some cases, particularly in younger patients, lesions resolve without intervention as the immune system clears them. In others, they persist indefinitely, and in a smaller proportion of cases they progress toward a form of skin cancer. The absolute risk of progression for any single lesion is low, but because actinic keratosis is common and clinics see a great deal of sun-exposed skin, early recognition and appropriate referral carry real value.

This is precisely why the finding belongs outside self-treatment or purely cosmetic handling: distinguishing actinic keratosis from other pigmented or scaly lesions, and monitoring it appropriately, is a diagnostic task for a trained clinician.

Distinguishing It From Other Presentations

Part of what makes actinic keratosis clinically significant is that it can resemble, or sit alongside, other skin changes that practitioners commonly see in an aesthetic setting — seborrhoeic keratosis, early basal cell carcinoma, and simple dry, flaky patches from environmental factors among them. Aesthetic practitioners performing routine skin assessments are often well positioned to notice a new or changing rough patch before a patient thinks to mention it, particularly on areas like the scalp part-line or the backs of the hands that a patient rarely inspects closely. Flagging it for proper diagnosis, rather than treating it as a texture concern to be resurfaced away, is the responsible course.

The Professional Treatment Landscape

Management of confirmed actinic keratosis is led by dermatology or an appropriately qualified prescribing clinician, and typically draws on one or more of the following approaches, deployed according to the extent and location of the lesions:

• Ablative approaches, such as cryotherapy or laser resurfacing, which physically destroy affected tissue.
• Topical pharmacological treatments, where a prescribed active ingredient is applied directly to the lesions over a defined course.
• Photodynamic therapy (PDT), in which a photosensitising agent is applied to the lesions and subsequently activated with a specific wavelength of light, triggering a reaction that targets the affected cells while generally preserving good cosmetic outcomes.

These are prescription-led, diagnosis-dependent treatments, and none of them are appropriate for a practitioner to initiate outside that framework.

Where an Aesthetic Clinic's Role Fits

For clinics without a prescribing remit, the practical contribution lies elsewhere: recognising suspicious lesions and referring appropriately, and — arguably the more consistent, everyday value — reinforcing photoprotection as part of every skin consultation. Rigorous, daily use of a broad-spectrum sunscreen is the single most evidence-backed measure for reducing further actinic damage and supporting any medical treatment a patient later undergoes. Suitable options for recommending or retailing to patients include broad-spectrum, high-SPF formulations such as ISDIN Fotoultra Spot Prevent SPF50 and Teoxane UVA Shield SPF50.

The Takeaway

Actinic keratosis is a common, cumulative consequence of sun exposure that sits between purely cosmetic and genuinely medical territory. Aesthetic practitioners are well placed to recognise it, refer appropriately, and champion the photoprotection habits that reduce further damage — while leaving diagnosis and active treatment to the clinicians whose remit that is.

To build out a photoprotection offering for patients, browse the medical skincare selection.